Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BRZE | DAN |
|---|---|---|
| Price | $26.61 | $28.10 |
| Change today | ▲ 4.68% | ▲ 0.79% |
| Market cap | $3.02B | $3.02B |
| Return, 3 months | +9.1% | +11.0% |
| Return, year to date | -22.4% | +19.6% |
| Return, 1 year | -8.1% | +46.2% |
| P/E (TTM) | -25.8 | 2.8 |
| P/B | 5.0 | 1.6 |
| P/E percentile vs own 5y | – | 54th |
| Dividend yield | – | 1.57% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +40.5% | +34.5% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 52 | 43 |
| 30-day volatility | 92.4% | 37.7% |
| Max drawdown, 1 year | -56.4% | -35.8% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
